Recombinant Rat APBB3 Protein，His

APBB3 (Amyloid Precursor Protein-Binding Family B Member 3) is a protein that has garnered significant interest in recent years due to its potential implications in neurodegenerative diseases, particularly Alzheimer's disease. This protein is involved in various cellular processes, including signal transduction and gene expression, and has shown affinity for binding to amyloid precursor proteins, which play a crucial role in the pathogenesis of Alzheimer's. The aggregation of amyloid-beta peptides, derived from these precursor proteins, is a hallmark of Alzheimer's pathology. Researchers have been investigating the functional role of APBB3 in modulating neuronal survival and synaptic function, as its interaction with other molecular partners may influence these critical processes. Moreover, mutations or dysregulation of APBB3 may contribute to the susceptibility or progression of neurodegenerative conditions. The study of APBB3, therefore, aims to elucidate its biological functions, investigate its potential as a therapeutic target, and enhance our understanding of Alzheimer’s disease mechanisms. The development of recombinant APBB3 protein allows for detailed structural and functional studies, paving the way for novel therapeutic strategies and biomarker identification in neurodegeneration. As research progresses, insights into APBB3 could unlock new avenues for treatment, ultimately contributing to improved outcomes for individuals affected by dementia-related disorders.